ORCID Rising

Publishers and scientific societies will require researchers to identify themselves using unique numeric codes.

Written byBob Grant
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

WIKIMEDIA, VAGLAName ambiguity may soon be a thing of the past, at least among members of the scientific community. Several major journal publishers and scientific societies have pledged to require submitting authors to sign up for an Open Researcher and Contributor ID (ORCID iD) number and use that number as a unique identifier. A variety of publishers—including PLOS, AAAS, IEEE, EMBO Press, eLife, The Royal Society, and the American Geophysical Union—promised to start requiring authors to provide an ORCID iD over the next year, in an open letter released today (January 7). “We encourage other publishers to join us in this initiative,” the letter read. “We hope that our action inspires the community, including researchers, research funders, and research institutions, to join us in adopting ORCID and making it easy for researchers to connect their iD to their contributions and affiliations.”

The move may help people more easily find the work and profiles of researchers with common surnames, such as Smith, Jones, Wang, or Nguyen. The Royal Society mandated the use of ORCID iDs starting this month (January 1); the other publishers will phase in the requirement throughout the year. “Publishers get together often, and we are constantly discussing how the system is evolving,” Stuart Taylor, publishing director of The Royal Society, told The Scholarly Kitchen. “I was speaking to a few like-minded publishers at a meeting on open science in Washington, and we soon realized that we could achieve more in terms of driving ORCID adoption if we worked together.”

Another publisher, Springer Nature, said it would continue to “encourage—but not require—ORCID IDs from authors ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Related Topics

Meet the Author

  • From 2017 to 2022, Bob Grant was Editor in Chief of The Scientist, where he started in 2007 as a Staff Writer. Before joining the team, he worked as a reporter at Audubon and earned a master’s degree in science journalism from New York University. In his previous life, he pursued a career in science, getting a bachelor’s degree in wildlife biology from Montana State University and a master’s degree in marine biology from the College of Charleston in South Carolina. Bob edited Reading Frames and other sections of the magazine.

    View Full Profile
Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Graphic of amino acid chains folded into proteins

Expi293™ PRO Expression System: Higher Yields Across a Wider Variety of Proteins

Thermo Fisher Logo